SPX Announces Agreement for Sale of European Power

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SPX Announces Agreement for Sale of European Power Generation Business Transaction Expected to Close by Year-End

CHARLOTTE, N.C., Nov. 23, 2016 (GLOBE NEWSWIRE) -- SPX Corporation (NYSE: SPXC ) announced that it has entered into an agreement for the sale of its European Power Generation business (the “Balcke-Dürr group,” or “Balcke-Dürr”) to mutares AG (“mutares”), a German-based publicly traded industrial holding company.  The closing of the transaction is expected to occur by December 31, 2016.

The terms of the purchase agreement include the sale of the subsidiaries comprising Balcke-Dürr in exchange for nominal cash at closing and a commitment by SPX to leave sufficient liquidity within Balcke-Dürr, including a loan from SPX, to support ongoing operations and the implementation of mutares’s strategic plan. A more detailed description of the transaction is provided in the company’s Form 8-K filed today with the United States Securities and Exchange Commission. 

Gene Lowe, President and CEO, remarked, “The agreement for the sale of Balcke-Dürr is another significant step forward on our value creation roadmap.  Our team has worked tirelessly to arrive at the best possible solution for delivering on our commitment to eliminate the losses from the underperforming portions of our Power Segment. With the completion of this transaction, and the earlier sale of our Dry Cooling business, SPX will substantially complete the transformation of the Power Segment, leaving the company with three strong platforms to continue executing on our growth strategy.”

As previously disclosed, the elimination of the underperforming portions of our Power Generation business would have the effect of increasing the company’s current Adjusted EPS* guidance for 2016 by more than $0.30, the majority of which is attributable to the sale of Balcke-Dürr. SPX anticipates that the transaction will qualify for discontinued operations presentation in our full-year 2016 financial statements, and now expects to report full-year Adjusted EPS* significantly in excess of our current guidance range of $1.00-$1.20.

About SPX Corporation:  Based in Charlotte, North Carolina, SPX Corporation is a leading supplier of highly engineered HVAC products, detection and measurement technologies and power equipment. With operations in about 20 countries, SPX Corporation had approximately $1.7 billion in annual revenue in 2015 and approximately 6,000 employees worldwide. SPX Corporation is listed on the New York Stock Exchange under the ticker symbol “SPXC.”  For more information, please visit www.spx.com .

About mutares AG :  Based in Munich, Germany, mutares AG is an industrial holding company that focuses on acquiring companies currently finding themselves in a special situation, such as owner or management succession or strategic repositioning. Getting engaged with its own teams, mutares actively supports its portfolio companies ensuring sustainable, long-term growth. The shares of mutares AG are traded on the Frankfurt Stock Exchange under the symbol MUX (ISIN: DE000A0SMSH2). For more information, please visit www.mutares.com .

*Non-GAAP financial measure. Adjusted EPS is calculated in a manner consistent with the presentation of Adjusted EPS in SPX’s press release dated November 3, 2016 and submitted as Exhibit 99.1 to SPX’s Current Report on Form 8-K dated November 3, 2016.  Because of the forward-looking nature of the estimate of Adjusted EPS, it is impractical to present a quantitative reconciliation of such measure to a comparable GAAP measure, and accordingly no such GAAP measure or reconciliation is being presented.

Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. Please read these results in conjunction with the company's documents filed with the Securities and Exchange Commission, including the company's annual reports on Form 10-K, and any amendments thereto, and quarterly reports on Form 10-Q. These filings identify important risk factors and other uncertainties that could cause actual results to differ from those contained in the forward-looking statements. Actual results may differ materially from these statements. The words “believe”, "expect," "anticipate," "project" and similar expressions identify forward-looking statements. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. In addition, estimates of future operating results are based on the company's existing operations and complement of businesses, which are subject to change.

Statements in this press release speak only as of the date of this press release, and SPX disclaims any responsibility to update or revise such statements.

Investor Contact: Paul Clegg, Vice President, Finance and Investor Relations Phone: 980-474-3806 E-mail: spx.investor@spx.com Media and Customer Contact: Vivek Dhir, Vice President, Global Marketing and Business Development Phone: 980-474-3703 E-mail: vivek.dhir@spx.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 358

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 239

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 239

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 27

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 94

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Booming Healthcare Asset Management Market

Updated Category News Views 189

Healthcare Asset Management Market Overview The Healthcare Asset Management market has been experiencing remarkable growth, with projections estimating its value to exceed USD 166.82 billion. This rapid expansion is driven by an impressive compound annual growth rate (CAGR) of 23.1% from 2024 to 2032. This article delves into the reasons behind this growth and what the...

Continue Reading
Chijet Motor Company Partners with EdgeAI for Token Acquisition

Updated Category News Views 133

Chijet Motor Company Announces Strategic Partnership Chijet Motor Company, Inc. (NASDAQ: CJET), proudly unveils its agreement with EdgeAI Frontier Technology Ltd. This partnership aims to secure up to $1 billion in EdgeAI tokens at a remarkable 20% discount off current market prices. This strategic collaboration transcends traditional operations, marking a significant...

Continue Reading
Myriad Genetics Navigates Market Trials Following Stock Dip

Updated Category News Views 138

Myriad Genetics Faces Market Challenges Myriad Genetics, Inc. (NASDAQ: MYGN) has recently hit a new 52-week low, marking a critical moment for the company with stock prices plummeting to $12.16. This decline highlights a tough market landscape for the firm, which specializes in genetic testing and precision medicine. Over the last six months, the stock has seen a...

Continue Reading
Veriff Expands into Latin America, Driving Global Identity Solutions

Updated Category News Views 184

Veriff Expands into Latin America Veriff, a pioneering company in AI-driven identity verification, is excited to announce its recent expansion into Latin America with the opening of a new headquarters in Brazil. This strategic initiative comes as part of Veriff's growth strategy, following exceptional increases in business volumes in the region, noted at more than two and...

Continue Reading
Analysts Adjust Predictions for Lam Research’s Upcoming Earnings

Updated Category News Views 125

Overview of Lam Research Earnings Anticipation Lam Research Corporation (NASDAQ:LRCX) is on the cusp of announcing its earnings for the first quarter. This significant moment is eagerly awaited by investors and analysts alike, particularly following a year of notable growth. Current estimates suggest that Lam Research is set to report earnings of $1.22 per share, a jump...

Continue Reading